Stocktoria
LISATA THERAPEUTICS, INC. LSTA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1995-11-03
LISATA THERAPEUTICS, INC. statistics & valuation
Market cap$30.6M
P / B2.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -10711.2% | -2240.9% | — | — | — |
| Net margin | -9756.5% | -1998.5% | — | — | — |
| FCF margin | -9398.2% | -1935.6% | — | — | — |
| Return on assets | -93.5% | -57.1% | -38.1% | -74.2% | -28.3% |
| Return on equity | -111.7% | -67.6% | -43.3% | -81.4% | -29.8% |
| Current ratio | 5.76 | 6.16 | 8.18 | 11.26 | 21.27 |
| Revenue growth | -83.0% | — | — | — | — |
Source: SEC EDGAR filings · CIK 0000320017 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.